Sean E. Aeder

Array ( [id] => 7307449 [patent_doc_number] => 20040141975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer' [patent_app_type] => new [patent_app_number] => 10/407484 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 98 [patent_figures_cnt] => 98 [patent_no_of_words] => 159301 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141975.pdf [firstpage_image] =>[orig_patent_app_number] => 10407484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206107 [patent_doc_number] => 20050043230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Use of long pentraxin ptx3 for the treatment of fgf-8 mediated tumour diseases' [patent_app_type] => utility [patent_app_number] => 10/492130 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2777 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043230.pdf [firstpage_image] =>[orig_patent_app_number] => 10492130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7438266 [patent_doc_number] => 20040002593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use' [patent_app_type] => new [patent_app_number] => 10/407866 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 36159 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002593.pdf [firstpage_image] =>[orig_patent_app_number] => 10407866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468079 [patent_doc_number] => 20040198969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor' [patent_app_type] => new [patent_app_number] => 10/405310 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 52730 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198969.pdf [firstpage_image] =>[orig_patent_app_number] => 10405310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 483716 [patent_doc_number] => 07220839 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells' [patent_app_type] => utility [patent_app_number] => 10/509096 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5974 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220839.pdf [firstpage_image] =>[orig_patent_app_number] => 10509096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930709 [patent_doc_number] => 20050281743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Cancer associated protein phosphatases and their uses' [patent_app_type] => utility [patent_app_number] => 10/509773 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18470 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281743.pdf [firstpage_image] =>[orig_patent_app_number] => 10509773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5770279 [patent_doc_number] => 20050266405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Analysis of apoptotic bodies in bodily fluids' [patent_app_type] => utility [patent_app_number] => 10/506703 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8098 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266405.pdf [firstpage_image] =>[orig_patent_app_number] => 10506703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5826946 [patent_doc_number] => 20060062781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Specific ab1\'-antibodies against tumour-associated antigen ca 125' [patent_app_type] => utility [patent_app_number] => 10/507046 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2294 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062781.pdf [firstpage_image] =>[orig_patent_app_number] => 10507046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82631 [patent_doc_number] => 07740845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Uses of monoclonal antibody 8H9' [patent_app_type] => utility [patent_app_number] => 10/505658 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 37 [patent_no_of_words] => 56671 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/740/07740845.pdf [firstpage_image] =>[orig_patent_app_number] => 10505658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7177803 [patent_doc_number] => 20050123920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Jade nucleic acids, proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/506266 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 23820 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123920.pdf [firstpage_image] =>[orig_patent_app_number] => 10506266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075234 [patent_doc_number] => 20050148502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43' [patent_app_type] => utility [patent_app_number] => 10/506226 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4659 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148502.pdf [firstpage_image] =>[orig_patent_app_number] => 10506226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770358 [patent_doc_number] => 20030216298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Peptide conjugated anti-cancer prodrugs' [patent_app_type] => new [patent_app_number] => 10/382240 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11416 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216298.pdf [firstpage_image] =>[orig_patent_app_number] => 10382240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019376 [patent_doc_number] => 20050221395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Methods and products based on oligomerization of stress proteins' [patent_app_type] => utility [patent_app_number] => 10/506097 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 50059 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221395.pdf [firstpage_image] =>[orig_patent_app_number] => 10506097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 662204 [patent_doc_number] => 07101557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'Combined tissue factor methods for coagulation and tumor treatment' [patent_app_type] => utility [patent_app_number] => 10/375741 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 61816 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101557.pdf [firstpage_image] =>[orig_patent_app_number] => 10375741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7414159 [patent_doc_number] => 20040025194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Beta chain-associated regulator of apoptosis' [patent_app_type] => new [patent_app_number] => 10/373228 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 36107 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20040025194.pdf [firstpage_image] =>[orig_patent_app_number] => 10373228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 330337 [patent_doc_number] => 07510832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'Molecular diagnosis and prognosis of carcinomas' [patent_app_type] => utility [patent_app_number] => 10/503782 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7662 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/510/07510832.pdf [firstpage_image] =>[orig_patent_app_number] => 10503782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 528028 [patent_doc_number] => 07183385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-27 [patent_title] => 'Phospho-specific antibodies to Flt3 and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/368912 [patent_app_country] => US [patent_app_date] => 2003-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 7274 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183385.pdf [firstpage_image] =>[orig_patent_app_number] => 10368912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740318 [patent_doc_number] => 20030157687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Human tissue inhibitor of metalloproteinase-4' [patent_app_type] => new [patent_app_number] => 10/366445 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 49771 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157687.pdf [firstpage_image] =>[orig_patent_app_number] => 10366445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5813837 [patent_doc_number] => 20060084056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Methods for selecting treatment regimens and predicting outcomes in cancer patients' [patent_app_type] => utility [patent_app_number] => 10/504287 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 42384 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084056.pdf [firstpage_image] =>[orig_patent_app_number] => 10504287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 477935 [patent_doc_number] => 07223542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => '36P6D5: secreted tumor antigen' [patent_app_type] => utility [patent_app_number] => 10/365254 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 33167 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223542.pdf [firstpage_image] =>[orig_patent_app_number] => 10365254 [rel_patent_id] =>[rel_patent_doc_number] =>)